
Children receiving 50 nmol PVX108 increased their tolerated peanut dose 2.4-fold, with no treatment-related anaphylaxis in the phase 2 trial.
Experts discuss the management of dry eye using conventional and new pharmacological treatments, as well as strategies for tailoring treatment approaches to individual patient characteristics.
1:00 Dry eye patient evaluation
7:00 Dry eye tests and diagnostics
12:00 Dry eye in contact lens wearers
16:00 Corneal sensitivity
17:45 Anti-inflammatory agents
20:30 Insurance challenges
22:00 Using compounding pharmacies
24:00 New dry eye treatments






